Enveric Biosciences, Inc. — Form D/A

Enveric Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2018-08-28. The offering totals $6.6M, of which $6.6M was reported sold. Industry: Business Services.

Offering

Issuer

Officers, directors & promoters (58)

Showing 25 of 58 people.

NameRoleLocation
Dimitrios AngelisDirectorDenver, CO
Srinidhi DevanurDirectorSuwanee, GA
David LuciDirectorJersey City, NJ
James ShadDirectorSuwanee, GA
Robert ShawahDirectorSuwanee, GA
Srinidhi DevanurExecutive OfficerSuwanee, GA
Brent KeltonExecutive OfficerAustin, TX
VIRAJ PATELExecutive OfficerSeattle, WA
David JohnsonDirectorGreenwood Village, CO
David JohnsonExecutive OfficerGreenwood Village, CO
Sheila W DeWittDirectorCambridge, MA
George W KeglerDirectorCambridge, MA
Kevin M CoveneyExecutive OfficerCambridge, MA
Marcus W SchabackerDirectorCambridge, MA
Frank W PasqualoneDirectorCambridge, MA
Michael D WebbDirectorCambridge, MA
Joseph E TuckerDirectorCambridge, MA
Joseph E TuckerExecutive OfficerCambridge, MA
Joseph TuckerDirectorNaples, FL
Joseph TuckerExecutive OfficerNaples, FL
Bob DagherExecutive OfficerNaples, FL
Marcus SchabackerDirectorNaples, FL
Douglas LindDirectorNaples, FL
Frank PasqualoneDirectorCambridge, MA
Frank PasqualoneRelated PersonCambridge, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2026-05-04D$5.0M$5.0M
2026-02-11D$1.5M$1.5M
2025-12-23D$107K$107K
2025-10-03D
2023-04-19D/A$12.8M$12.8M
2022-08-05D$8.6M$8.6M
2021-02-24D$8.4M
2021-01-20D$8.2M
2018-08-02D$6.0M$6.0M

More